Живи долго! Научный подход к долгой молодости и здоровью. Майкл Грегер
Читать онлайн книгу.
E, Monti D, Franceschi C. Inflamm-ageing. Curr Opin Clin Nutr Metab Care. 2013;16(1):14–20. https://pubmed.ncbi.nlm.nih.gov/23132168/
1025
Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908(1):244–54. https://pubmed.ncbi.nlm.nih.gov/10911963/
1026
Tang Y, Fung E, Xu A, Lan HY. C-reactive protein and ageing. Clin Exp Pharmacol Physiol. 2017;44(S1):9–14. https://pubmed.ncbi.nlm.nih.gov/28378496/
1027
Tait JL, Duckham RL, Milte CM, Main LC, Daly RM. Associations between inflammatory and neurological markers with quality of life and well-being in older adults. Exp Gerontol. 2019;125:110662. https://pubmed.ncbi.nlm.nih.gov/31323254/
1028
Tang Y, Fung E, Xu A, Lan HY. C-reactive protein and ageing. Clin Exp Pharmacol Physiol. 2017;44(S1):9–14. https://pubmed.ncbi.nlm.nih.gov/28378496/
1029
Rajasekaran S, Tangavel C, Anand SV KS, et al. Inflammaging determines health and disease in lumbar discs – evidence from differing proteomic signatures of healthy, aging, and degenerating discs. Spine J. 2020;20(1):48–59. https://pubmed.ncbi.nlm.nih.gov/31125691/
1030
Pedersen BK. Anti-inflammation – just another word for anti-ageing? J Physiol. 2009;587(Pt 23):5515. https://pubmed.ncbi.nlm.nih.gov/19959548/
1031
Barron E, Lara J, White M, Mathers JC. Blood-borne biomarkers of mortality risk: systematic review of cohort studies. PLoS ONE. 2015;10(6):e0127550. https://pubmed.ncbi.nlm.nih.gov/26039142/
1032
Bottazzi B, Riboli E, Mantovani A. Aging, inflammation and cancer. Semin Immunol. 2018;40:74–82. https://pubmed.ncbi.nlm.nih.gov/30409538/
1033
Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging: an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908(1):244–54. https://pubmed.ncbi.nlm.nih.gov/10911963/
1034
Puzianowska-Kuznicka M, Owczarz M, Wieczorowska-Tobis K, et al. Interleukin-6 and C-reactive protein, successful aging, and mortality: the PolSenior study. Immun Ageing. 2016;13:21. https://pubmed.ncbi.nlm.nih.gov/27274758/
1035
Franceschi C, Ostan R, Santoro A. Nutrition and inflammation: are centenarians similar to individuals on calorie-restricted diets? Annu Rev Nutr. 2018;38:329–56. https://pubmed.ncbi.nlm.nih.gov/29852087/
1036
Bonafè M, Olivieri F, Cavallone L, et al. A gender – dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol. 2001;31(8):2357–61. https://pubmed.ncbi.nlm.nih.gov/11500818/
1037
Man MQ, Elias PM. Could inflammaging and its sequelae be prevented or mitigated? Clin Interv Aging. 2019;14:2301–4. https://pubmed.ncbi.nlm.nih.gov/31920294/
1038
Man MQ, Elias PM. Could inflammaging and its sequelae be prevented or mitigated? Clin Interv Aging. 2019;14:2301–4. https://pubmed.ncbi.nlm.nih.gov/31920294/
1039
Hu L, Mauro TM, Dang E, et al. Epidermal dysfunction leads to an age-associated increase in levels of serum inflammatory cytokines. J Invest Dermatol. 2017;137(6):1277–85. https://pubmed.ncbi.nlm.nih.gov/28115059/
1040
Ye L, Mauro TM, Dang E, et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatol Venereol. 2019;33(11):2197–201. https://pubmed.ncbi.nlm.nih.gov/30835878/
1041
Arai Y, Martin-Ruiz CM, Takayama M, et al. Inflammation, but not telomere length, predicts successful ageing at extreme old age: a longitudinal study of semi-supercentenarians. EBioMedicine. 2015;2(10):1549–58. https://pubmed.ncbi.nlm.nih.gov/26629551/
1042
Furman D, Campisi J, Verdin E, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med. 2019;25(12):1822–32. https://pubmed.ncbi.nlm.nih.gov/31806905/
1043
Chambers ES, Akbar AN. Can blocking inflammation enhance immunity during aging? J Allergy Clin Immunol. 2020;145(5):1323–31. https://pubmed.ncbi.nlm.nih.gov/32386656/
1044
Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and ‘garb-aging.’ Trends Endocrinol. Metab. 2017;28(3):199–212. https://pubmed.ncbi.nlm.nih.gov/27789101/
1045
Monti D, Ostan R, Borelli V, Castellani G, Franceschi C. Inflammaging and human longevity in the omics era. Mech Ageing Dev. 2017;165(Pt B):129–38. https://pubmed.ncbi.nlm.nih.gov/28038993/
1046
Meydani SN, Das SK, Pieper CF, et al. Long-term moderate calorie restriction inhibits inflammation without impairing cell-mediated immunity: a randomized controlled trial in non-obese humans. Aging (Albany NY). 2016;8(7):1416–31. https://pubmed.ncbi.nlm.nih.gov/27410480/
1047
Choi J, Joseph L, Pilote L. Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obes Rev. 2013;14(3):232–44. https://pubmed.ncbi.nlm.nih.gov/23171381/
1048
Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–63. https://pubmed.ncbi.nlm.nih.gov/28721154/
1049
Pasarica M, Sereda OR, Redman LM, et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes. 2009;58(3):718–25. https://pubmed.ncbi.nlm.nih.gov/19074987/
1050
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796–808. https://pubmed.ncbi.nlm.nih.gov/14679176/
1051
Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347–55. https://pubmed.ncbi.nlm.nih.gov/16150820/
1052
Bays HE, González-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008;6(3):343–68. https://pubmed.ncbi.nlm.nih.gov/18327995/
1053
Welsh P, Polisecki